Health
Oxford vaccine stimulates broad antibody and T cell functions – Medical Xpress
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing…
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
These findings are reported in two papers, both released in the peer-reviewed journal Nature Medicine.
Previous studies have shown that in order to develop any vaccine against SARS-CoV-2 coronavirus,…
-
General21 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
Business11 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News23 hours agoLogan City Council to pull out of federal government Climate Active program due to financial pressure, transparency concerns
-
Noosa News20 hours agoCharlie the therapy dog reduces stress – Proctor